- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/18 - Radicals substituted by singly bound oxygen or sulfur atoms
Patent holdings for IPC class C07D 317/18
Total number of patents in this class: 32
10-year publication summary
|
0
|
0
|
3
|
2
|
2
|
1
|
0
|
2
|
4
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bio-Pharm Solutions Co., Ltd. | 55 |
4 |
| Sumitomo Chemical Company, Limited | 9016 |
3 |
| JSR Corporation | 2554 |
2 |
| LIBRAMEDICINA, Inc. | 4 |
2 |
| NMD Pharma A/S | 48 |
2 |
| BASF SE | 21303 |
1 |
| AstraZeneca AB | 2814 |
1 |
| FUJIFILM Corporation | 30514 |
1 |
| Semiconductor Energy Laboratory Co., Ltd. | 11821 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 6096 |
1 |
| Cognis IP Management GmbH | 549 |
1 |
| Daiso Co., Ltd. | 41 |
1 |
| Fresenius Kabi Oncology Limited | 70 |
1 |
| Gfbiochemicals Limited | 50 |
1 |
| Gilead Sciences, Inc. | 2222 |
1 |
| NOK Corporation | 2299 |
1 |
| Segetis, Inc. | 38 |
1 |
| Shenzhen Capchem Technology Co., Ltd. | 326 |
1 |
| Symrise AG | 1849 |
1 |
| Veiled Therapeutics, LLC | 11 |
1 |
| Other owners | 4 |